The effects of HSP27 on gemcitabine-resistant pancreatic cancer cell line through snail

被引：0
|
作者：
Zhang, Song [1 ]
Zou, Xiaoping [1 ]
机构：
[1] Nanjing Drum Tower Hosp, Nanjing, Jiangsu, Peoples R China
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2013年 / 28卷
关键词：
gemcitabine; HSP27; Snail; ERCC1;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：882 / 882
页数：1
相关论文
共 50 条
  • [21] Triptolide Cooperates With Cisplatin to Induce Apoptosis in Gemcitabine-Resistant Pancreatic Cancer
    Zhu, Wenbo
    Li, Jingjie
    Wu, Sihan
    Li, Shifeng
    Le, Liang
    Su, Xingwen
    Qiu, Pengxin
    Hu, Haiyan
    Yan, Guangmei
    PANCREAS, 2012, 41 (07) : 1029 - 1038
  • [22] Disrupting glutamine metabolic pathways to sensitize gemcitabine-resistant pancreatic cancer
    Ru Chen
    Lisa A Lai
    Yumi Sullivan
    Melissa Wong
    Lei Wang
    Jonah Riddell
    Linda Jung
    Venu G. Pillarisetty
    Teresa A. Brentnall
    Sheng Pan
    Scientific Reports, 7
  • [23] Disrupting glutamine metabolic pathways to sensitize gemcitabine-resistant pancreatic cancer
    Chen, Ru
    Lai, Lisa A.
    Sullivan, Yumi
    Wong, Melissa
    Wang, Lei
    Riddell, Jonah
    Jung, Linda
    Pillarisetty, Venu G.
    Brentnall, Teresa A.
    Pan, Sheng
    SCIENTIFIC REPORTS, 2017, 7
  • [24] Molecular profiling and specific targeting of gemcitabine-resistant subclones in heterogeneous pancreatic cancer cell populations
    Faerber, Benedikt
    Lapshyna, Olga
    Kuenstner, Axel
    Kohl, Michael
    Sauer, Thorben
    Bichmann, Kira
    Heckelmann, Benjamin
    Watzelt, Jessica
    Honselmann, Kim
    Bolm, Louisa
    ten Winkel, Meike
    Busch, Hauke
    Ungefroren, Hendrik
    Keck, Tobias
    Gemoll, Timo
    Wellner, Ulrich F.
    Braun, Ruediger
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [25] HSP27 expression is associated with increased gemcitabine resistance in cholangiocarcinoma cell lines
    Romani, A. A.
    Desenzani, S.
    Soliani, P.
    Borghetti, A. F.
    BIOMEDICINE & PHARMACOTHERAPY, 2008, 62 (08) : 514 - 515
  • [26] Sclareolide enhances gemcitabine-induced cell death through mediating the NICD and Gli1 pathways in gemcitabine-resistant human pancreatic cancer
    Chen, Sheng
    Wang, Ye
    Zhang, Wen-Long
    Dong, Mao-Sheng
    Zhang, Jian-Hua
    MOLECULAR MEDICINE REPORTS, 2017, 15 (04) : 1461 - 1470
  • [27] An exploratory study on the mechanism of pralatrexate killing gemcitabine-resistant pancreatic cancer cells
    Weng, W.
    Hong, J.
    Jiang, D.
    Chen, B.
    Zheng, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S431 - S431
  • [28] Zidovudine, an anti-viral drug, resensitizes gemcitabine-resistant pancreatic cancer cells to gemcitabine by inhibition of the Akt-GSK3β-Snail pathway
    Namba, T.
    Kodama, R.
    Moritomo, S.
    Hoshino, T.
    Mizushima, T.
    CELL DEATH & DISEASE, 2015, 6 : e1795 - e1795
  • [29] Zidovudine, an anti-viral drug, resensitizes gemcitabine-resistant pancreatic cancer cells to gemcitabine by inhibition of the Akt-GSK3β-Snail pathway
    T Namba
    R Kodama
    S Moritomo
    T Hoshino
    T Mizushima
    Cell Death & Disease, 2015, 6 : e1795 - e1795
  • [30] PEFG salvage therapy inpatients with gemcitabine-resistant advanced pancreatic cancer (PC)
    Cereda, S.
    Mazza, E.
    Passoni, P.
    Nicoletti, R.
    Balzano, G.
    Zerbi, A.
    Staudacher, C.
    di Carlo, V
    Reni, M.
    ANNALS OF ONCOLOGY, 2006, 17 : 58 - 59
12345